Arterial Occlusion Precipitated by Cisplatinbased Chemotherapy
Open Access
- 1 November 2010
- journal article
- Published by MDPI AG in Current Oncology
- Vol. 17 (6) , 71-72
Abstract
Cisplatin-based therapy is curative in testicular cancer. Adverse effects of cisplatin-based chemotherapy include dose-dependent myelosuppression, nephrotoxicity, neurotoxicity, and ototoxicity. By contrast, chemotherapy-associated vascular complications are unpredictable. Few incidents of digital gangrene with cisplatin have been reported. Here, we present a patient who developed arterial occlusion leading to gangrene of the toe after cisplatinbased chemotherapy.Keywords
This publication has 6 references indexed in Scilit:
- Aortic occlusion in patients treated with Cisplatin-based chemotherapy.2006
- Thromboembolic Events During Chemotherapy for Germ Cell Cancer: A Cohort Study and Review of the LiteratureJournal of Clinical Oncology, 2000
- Use of carboplatin in germ cell tumors of the testis.1992
- Acute cerebrovascular event after cisplatin-based chemotherapy for testicular cancerThe Lancet, 1991
- Vascular toxicity associated with antineoplastic agents.Journal of Clinical Oncology, 1986
- Elevated Plasma von Willebrand Factor Levels and Arterial Occlusive Complications Associated with Cisplatin-Based ChemotherapyOncology, 1985